IP Library Granted Patent US 9,062,026
Granted Patent B2
US 9,062,026 · App. 13/946,795 · Granted Jun 23, 2015

Fused pyrimidines and substituted quinazolines as inhibitors of p97

Inventors: Han-Jie Zhou (Foster City, CA); Francesco Parlati (San Francisco, CA); David Wustrow (Los Gatos, CA)
Assignee: Cleave Biosciences, Inc.
C07D403/04C07D405/04C07D471/04C07D473/34C07D487/04C07D491/048C07D491/052C07D495/04C07D513/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,062,026
App. No.
13/946,795
Granted
Jun 23, 2015
Kind
B2
Abstract

A group of fused two ring pyrimidine compounds having a heterocycles substituent at the 2 position and a substituted amine at the 4 position as well as optional aliphatic, functional and/or aromatic components substituted at other positions of the pyrimidine and other ring are disclosed. In addition a group of quinazoline compounds having similar substituents at the 2 and 4 positions as well as at other positions are disclosed. These compounds are inhibitors of the AAA proteasome complex containing p97 and are effective medicinal agents for treatment of diseases associated with p97 bioactivity.

Claims (15)

1. A fused pyrimidine compound having a systematic name selected from the group consisting of:

1-[4-(benzylamino)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-2-methyl-1H-1,3-benzodiazole-4-carboxamide;

1-[4-(benzylamino)-5H,6H,7H,8H-pyrido[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide;

1-[4-(benzylamino)-5H,7H,8H-pyran[4,3-d]pyrimidin-2-yl]-2-methoxy-1H-indole-4-carboxamide;

1-[4-(benzylamino)-5H,7H,8H-pyran[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide;

N-benzyl-2-(2-ethoxy-1H-indol-1-yl)-5,6,7,8-tetrahydroquinazolin-4-amine;

N-benzyl-2-(2-methoxy-1H-benzo[d]imidazol-1-yl)-5,6,7,8-tetrahydroquinazolin-4-amine;

N-benzyl-2-(2-methoxy-1H-indol-1-yl)-5,6,7,8-tetrahydroquinazolin-4-amine;

N-benzyl-2-(2-methoxy-1H-indol-1-yl)-5H,7H,8H-pyran[4,3-d]pyrimidin-4-amine;

N-benzyl-2-(2-methyl-1H-1,3-benzo diazol-1-yl)-5,6,7,8-tetrahydroquinazolin-4-amine;

N-benzyl-2-(2-methyl-1H-indol-1-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-amine;

N-benzyl-2-(2-methyl-1H-indol-1-yl)-5H,7H,8H-pyran[4,3-d]pyrimidin-4-amine

or any salt or hydrate thereof.

2. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and an amount of a compound of claim 1 which is effective as an inhibitor of the AAA family member Valosin containing protein.

3. A pharmaceutical composition according to claim 2 wherein the Valosin containing protein is in a human cell.

Assignments (4)
CHANGE OF NAME Recorded Jul 24, 2023
From: CLEAVE BIOSCIENCES, INC.
To: CLEAVE THERAPEUTICS, INC.
Reel/Frame 064357/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2023
From: CLEAVE THERAPEUTICS, INC.
To: EIKON THERAPEUTICS, INC.
Reel/Frame 064118/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2015
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO; WUSTROW, DAVID
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 034789/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2013
From: ZHOU, HAN-JIE; PARLATI, FRANCESCO
To: CLEAVE BIOSCIENCES, INC.
Reel/Frame 031490/0187 →
Continuity (3)
Provisional Application 61674144 · Jul 20, 2012
Provisional Application 61737666 · Dec 14, 2012
Related Publication 20140024661A1 · Jan 23, 2014